Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (590)	2/18/1999 9:29:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

Mike: I don't know enough about the subject to judge it. Post away! I will say that I am fascinated by agents that can cause demyelination. We (John Fleming et al.) once made some antibodies against a mouse hepatitis virus (JHM) that causes a MS-like encephalitic disease in SJL mice. We isolated an anti-E2 MAb that, when virus isolates were propagated in its presence, selected variants with reduced neurovirulence. Nonetheless, there was still pronounced demyelination. Interesting stuff, but.... I'm off-topic. ;-) Go! Rick